Levosulpiride acts as an antagonist of which central dopamine receptor
## **Core Concept**
Levosulpiride is a substituted benzamide drug that acts primarily as a dopamine receptor antagonist. It is specifically used for its prokinetic and antiemetic properties. The drug's mechanism of action is closely related to its interaction with dopamine receptors in the brain and gastrointestinal tract.
## **Why the Correct Answer is Right**
Levosulpiride exerts its effects mainly by antagonizing the **D2 receptors**, which are a subtype of dopamine receptors. This action is significant in the chemoreceptor trigger zone of the central nervous system and in the gastrointestinal tract, where it enhances gastrointestinal motility. The antagonism of D2 receptors in the pituitary gland also leads to an increase in prolactin levels. Levosulpiride's specificity for D2 receptors is crucial for its therapeutic effects, including its use in treating gastrointestinal disorders and as an antipsychotic.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While sulpiride does have some affinity for D1 receptors, its primary and most significant action related to its therapeutic effects is not through D1 receptor antagonism.
- **Option C:** The D3 and D4 receptors are also part of the dopamine receptor family, but levosulpiride's primary action is not described as being mainly through these receptors.
- **Option D:** D5 receptors are not typically associated with the primary mechanism of action of levosulpiride.
## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that because levosulpiride can cause hyperprolactinemia (an increase in prolactin levels) due to its D2 receptor antagonism in the pituitary gland, it can have effects like galactorrhea and amenorrhea. This side effect profile is relevant for understanding the drug's clinical implications.
## **Correct Answer:** .